MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Vaccine Development & Manufacturing
BioVex
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Vaccines
*Architects: Vaccine Development & Manufacturing
*Industry: Massachusetts
Companies: Acquired_(M&A)
Finance & Acquisitions: Amgen
Children
2009: BioVex Raises $40M for Cancer-Fighting Virus (2009)
2011: Amgen to Acquire BioVex for Up To $1B, to Obtain Cancer-Killing Virus Therapy (2011)
2012: Biotech VCs, in Shadow of Tech, Start Delivering More Big Hits = $75million or More (2012)
Developing vaccines for the treatment of cancer and chronic infectious diseases.
Founded 1997
The acquisition includes OncoVEX(GM-CSF), a novel investigational oncolytic vaccine in Phase 3 clinical development that may represent a new approach to treating melanoma and head and neck cancer.
The company has two proprietary vaccine platforms (OncoVEX and ImmunoVEX).
Woburn, Massachusetts